Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Mar. 31, 2022
Current assets    
Cash and cash equivalents $ 75,058 $ 126,768
Restricted cash 500 394
Accounts receivable, net 178,189 263,139
Prepaid expenses and other current assets 12,319 20,570
Total current assets 266,066 410,871
Property and equipment, net 39,327 31,086
Right-of-use assets 10,073 15,439
Intangible assets, net 379,632 440,589
Goodwill 561,576 559,792
Other non-current assets 9,882 732
TOTAL ASSETS 1,266,556 1,458,509
Current liabilities    
Accounts payable 119,338 167,858
Accrued license fees and revenue share 69,221 95,170
Accrued compensation 10,984 28,775
Acquisition purchase price liabilities 0 50,000
Current portion of debt 0 12,500
Other current liabilities 21,377 30,960
Total current liabilities 220,920 385,263
Long-term debt, net of debt issuance costs 410,522 520,785
Deferred tax liabilities, net 13,940 19,976
Other non-current liabilities 13,919 16,270
Total liabilities 659,301 942,294
Commitments and contingencies
Stockholders’ equity    
Preferred stock 100 100
Common stock 10 10
Additional paid-in capital 822,217 745,661
Treasury stock (758,125 shares at March 31, 2023, and March 31, 2022) (71) (71)
Accumulated other comprehensive loss (41,945) (39,341)
Accumulated deficit (175,115) (191,788)
Total stockholders’ equity 605,196 514,571
Non-controlling interest 2,059 1,644
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 1,266,556 $ 1,458,509